Literature DB >> 15521331

Comparison of the TSI Model 3306 Impactor Inlet with the Andersen Cascade Impactor: solution metered dose inhalers.

Paul B Myrdal1, Stephen W Stein, Erik Mogalian, William Hoye, Abhishek Gupta.   

Abstract

The product performance of a series of solution Metered Dose Inhalers (MDIs) were evaluated using the TSI Model 3306 Impactor Inlet and the Andersen Cascade Impactor (ACI). The goal of the study was to test whether the fine particle and coarse particle depositions obtained using the Model 3306 were comparable to those results obtained by ACI testing. The analysis using the Model 3306 was performed as supplied by the manufacturer as well as with 20 cm and 40 cm vertical extensions that were inserted between the Model 3306 and the USP Inlet. Nine different solution formulations were evaluated. The drug concentrations ranged from 0.08 to 0.8% w/w and the ethanol cosolvent concentration varied between 5 and 20% w/w. In general, it was found that good correlations between the two instruments were obtained. However, for formulations containing 10-20% w/w ethanol it is shown that an extension fitted to the Model 3306 yielded an improved correlation to those obtained from the ACI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521331     DOI: 10.1081/ddc-200034575

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  4 in total

1.  Effect of oropharyngeal length in drug lung delivery via suspension pressurized metered dose inhalers.

Authors:  T Ehtezazi; D R Allanson; I D Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

2.  The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.

Authors:  J P Mitchell; M W Nagel; V Avvakoumova; H MacKay; R Ali
Journal:  AAPS PharmSciTech       Date:  2009-03-17       Impact factor: 3.246

Review 3.  Non-impactor-based methods for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs).

Authors:  Jolyon Mitchell; Richard Bauer; Svetlana Lyapustina; Terrence Tougas; Volker Glaab
Journal:  AAPS PharmSciTech       Date:  2011-07-22       Impact factor: 3.246

4.  Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.

Authors:  Julie A Harris; Stephen W Stein; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.